###begin article-title 0
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 30 35 <span type="species:ncbi:9606">human</span>
Transcriptional repression of human cad gene by hypoxia inducible factor-1alpha
###end article-title 0
###begin p 1
The authors wish it to be known that, in their opinion, the first two authors should be regarded as joint First Authors
###end p 1
###begin p 2
###xml 606 645 606 645 <email xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">journals.permissions@oxfordjournals.org</email>
The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact journals.permissions@oxfordjournals.org
###end p 2
###begin p 3
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">De novo</italic>
###xml 144 151 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 601 604 597 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 708 711 704 707 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 870 873 866 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1112 1115 1096 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1125 1132 1109 1116 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1166 1169 1150 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 409 414 <span type="species:ncbi:9606">human</span>
###xml 595 600 <span type="species:ncbi:9606">human</span>
De novo biosynthesis of pyrimidine nucleotides provides essential precursors for DNA synthesis and cell proliferation. The first three steps of de novo pyrimidine biosynthesis are catalyzed by a multifunctional enzyme known as CAD (carbamoyl phosphate synthetase-aspartate carbamoyltransferase-dihydroorotase). In this work, a decrease in CAD expression is detected in numerous cell lines and primary culture human stromal cells incubated under hypoxia or desferrioxamine (DFO)-induced HIF-1alpha accumulation. A putative hypoxia response element (HRE) binding matrix is identified by analyzing human cad-gene promoter using a bioinformatic approach. Promoter activity assays, using constructs harboring the cad promoter (-710/+122) and the -67/HRE fragment (25-bases), respectively, demonstrate the suppression of reporter-gene expression under hypoxia. Suppression of cad-promoter activity is substantiated by forced expression of wild-type HIF-1alpha but abolished by overexpression of dominant-negative HIF-1alpha. A chromatin immunoprecipitation assay provides further evidence that HIF-1alpha binds to the cad promoter in vivo. These data demonstrate that the cad-gene expression is repressed by HIF-1alpha, which represents a functional link between hypoxia and cell-cycle arrest.
###end p 3
###begin title 4
INTRODUCTION
###end title 4
###begin p 5
###xml 341 342 341 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
Hypoxia is an environmental stress that trigger with important implications in the pathogenesis of major causes of mortality including cancer, cerebral and myocardial ischemia, preeclampsia, and chronic heart and lung diseases. In recent years, many studies have shown that hypoxia can inhibit or even completely abolish cell proliferation (1-8), which is directly involved in the chemoresistance and radioresistance of hypoxic tumors because, chemo- and radiotherapy are efficient only against rapidly dividing cells. Thus, understanding the mechanisms responsible for cell-cycle arrest under hypoxic stress might help to circumvent these two forms of resistance.
###end p 5
###begin p 6
###xml 298 299 275 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b9">9</xref>
###xml 499 501 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b10">10</xref>
###xml 648 650 610 612 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b11">11</xref>
###xml 651 653 613 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b13">13</xref>
###xml 484 489 <span type="species:ncbi:9606">human</span>
The expression of hypoxia-responsive genes is regulated primarily by the transcription factor hypoxia-inducible factor (HIF). HIF consists of an inducible alpha subunit and a constitutively expressed beta subunit. Three variants of HIF-alpha (HIF-1alpha, -2alpha and -3alpha) have been identified (9); all of them dimerize with HIF-1beta (also known as aryl hydrocarbon nuclear translocator, ARNT) to form a heterodimeric functional unit. HIF-1alpha is expressed in most, if not all, human tissues (10), while HIF-2alpha and HIF-3alpha are expressed in more restricted tissues and developing stages such as the fetal lung and vascular endothelium (11-13). In addition, HIF-1alpha appears to play a general role in the transcriptional regulation of all cells in response to hypoxia, whereas HIF-2alpha and HIF-3alpha play more limited or specialized roles in oxygen homeostasis.
###end p 6
###begin p 7
###xml 16 17 16 17 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 18 19 18 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 315 316 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 317 318 313 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 578 579 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b3">3</xref>
###xml 580 582 568 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b14">14</xref>
###xml 795 796 783 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b8">8</xref>
###xml 1138 1139 1122 1123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
Recent studies (1-3) have demonstrated that hypoxia may lead to apoptosis of some transformed cell lines, while non-transformed cells are viable under hypoxic condition but are arrested in the G1/S-phase. Upregulation of HIF-1alpha caused by hypoxia inhibits cell-cycle progression in most normal and cancer cells (4-8). However, the mechanism of HIF-1alpha-induced cell-cycle arrest has not been uniformly resolved. Hypoxia-induced cell-cycle arrest causes the elevation of checkpoint proteins such as p53, p21 and p27 in direct relation to the expression level of HIF-1alpha (3,14). In contrast, a recent study demonstrated that embryonic fibroblast cells without p21 and p27 are capable of hypoxia-induced S-phase arrest, but that re-entry into the cell-cycle after reoxygenation is delayed (8). Most importantly, direct evidence of the transcriptional regulation of these checkpoint proteins by HIF-1alpha has never been demonstrated. Therefore, it is hypothesized that the elevation of checkpoint proteins under hypoxia is the secondary barrier of cell-cycle arrest and that a nucleotide shortage is the primary cause of the arrest (1).
###end p 7
###begin p 8
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 396 403 396 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
The de novo biosynthesis of pyrimidine nucleotides provides essential precursors for DNA synthesis and cell proliferation. Pyrimidine biosynthesis is not only a prerequisite for cells to enter the S-phase, but also it plays a dominant role in regulating cell-cycle progression due to the increased demand for nucleotides for DNA synthesis in rapidly proliferating cells. The first three steps of de novo pyrimidine biosynthesis are catalyzed by a multifunctional cytoplasmic enzyme known as CAD (carbamoyl phosphate synthetase-aspartate carbamoyltransferase-dihydroorotase) (15,16).
###end p 8
###begin p 9
###xml 93 100 93 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 184 187 184 187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 449 456 449 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 487 489 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b17">17</xref>
###xml 582 585 582 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 859 862 859 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 928 931 928 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b18">18</xref>
###xml 945 947 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b19">19</xref>
###xml 178 183 <span type="species:ncbi:9606">human</span>
Over the past decade, extensive advances have been made in elucidating the mechanisms of the de novo biosynthesis of pyrimidine nucleotide in mammalian cells. The cloning of the human cad gene and the characterization of its properties provided the major breakthrough for our understanding of the principles and regulation of pyrimidine biosynthesis in cancerous and non-cancerous cells. It is clear that CAD catalyzes the rate-limiting step in the de novo pyrimidine synthetic pathway (17), and that it therefore controls the rate of DNA synthesis. Transcriptional upregulation of cad promoter by growth factors and steroids that ultimately leads to an increase in cell proliferation has been reported. Mitogen-activated protein kinase (MAPK) and the transcription factor c-Myc mediates the growth-factor-induced CAD overexpression, and estrogen upregulates cad-promoter activity via the binding of ER and SP1 to the GC box of cad promoter (18,19).
###end p 9
###begin p 10
###xml 158 159 158 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 160 162 160 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b20">20</xref>
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b21">21</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 663 666 655 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 766 774 754 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 779 786 767 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The biosynthesis of pyrimidine nucleotides is inhibited by hypoxia, which ultimately leads to reduced DNA synthesis, hence inhibiting cell-cycle progression (7,20,21). Addition of exogenous pyrimidine nucleotides causes re-entry into the S-phase and initiates replication in hypoxic cells (7). Because CAD controls the first three enzymatic activities of pyrimidine nucleotide biosynthesis, reducing pyrimidine nucleotide production in hypoxic cells may be mediated by inhibiting CAD expression. Furthermore, HIF-1alpha is the master transcription factor in regulating hypoxia-responsive gene expression; thus, we hypothesize that HIF-1alpha may directly inhibit cad under hypoxia condition. This study aims to investigate regulation of CAD by HIF-1alpha using both in vitro and in vivo approaches.
###end p 10
###begin title 11
MATERIALS AND METHODS
###end title 11
###begin title 12
Cell culture and hypoxia treatment
###end title 12
###begin p 13
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b22">22</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b23">23</xref>
###xml 382 383 382 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 588 589 576 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 596 597 584 585 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 607 608 595 596 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 150 156 <span type="species:ncbi:9913">bovine</span>
###xml 174 179 <span type="species:ncbi:9606">human</span>
Cell lines were maintained in specific culture media recommended by the American Type Culture Collection (ATCC), and were supplemented with 10% fetal bovine serum (FBS). The human endometrial stromal cells were purified and cultured in DMEM/F12 medium with 10% FBS, as previously described (22,23). Between 18-24 h before undergoing hypoxia, cells were plated at a density of 5 x 105 cells per 30 mm glass dish. The medium was changed approximately1 h before treatment to assure an adequate amount of nutrient and growth factor. Hypoxic treatment was carried out in an incubator with 1% O2, 5% CO2 and 94% N2, or with desferrioxamine (DFO), as indicated. Oxygen concentration was monitored using an oxygen electrode (OS1000; Oxygen Sensors, Inc, Frazer, PA).
###end p 13
###begin title 14
RNA isolation and real-time RT-PCR
###end title 14
###begin p 15
###xml 788 789 760 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1178 1180 1150 1152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
Total RNA was isolated from cells using a kit (RNeasy Mini Kit; Qiagen, Valencia, CA) according to the manufacturer's instructions. RNA concentrations were determined using UV-absorption at 260 nm, and then subjected to reverse-transcription at 42degreesC for 60 min, denaturing, and PCR amplification using a thermal cycler (ABI 7900; Applied Biosystems, Foster City, CA). To determine the amounts of CAD transcript, real-time RT-PCR was conducted. In this reaction, SYBR Green I was added to the PCR master mix and served as a fluorescence source for laser detection. The cycling conditions were 95degreesC for 10 min, 40 cycles at 95degreesC for 15 s and 60degreesC for 1 min. The reaction data were expressed as copies/microg of RNA, after converting the number of cycle thresholds (Ct)-the PCR cycle number at which the fluorescent signal in each reaction reaches a preset threshold above background-to absolute value according to the standard curve. A dissociation curve was created using the built-in melting-curve program to confirm the presence of a single PCR product. 18S rRNA was used as an internal control, for which the primer sequences were previously reported (24).
###end p 15
###begin title 16
Plasmids, transfection, and promoter-activity assays
###end title 16
###begin p 17
###xml 258 261 242 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 394 400 378 384 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">gctagc</underline>
###xml 443 449 427 433 <underline xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ctcgag</underline>
###xml 715 718 699 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 39 42 <span type="species:ncbi:9685">Cat</span>
###xml 117 120 <span type="species:ncbi:9685">Cat</span>
###xml 252 257 <span type="species:ncbi:9606">Human</span>
###xml 709 714 <span type="species:ncbi:9606">human</span>
###xml 773 777 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Human HIF-1alpha CEP4/HIF-1alpha (ATCC Cat no.: MBA-2) and dominant-negative form HIF-alpha pCEP4/HIF-1alphaDN (ATCC Cat no.: MBA-7) plasmids were purchased from the American Type Culture Collection (ATCC, The Johns Hopkins University, Baltimore, MD). Human cad promoter (-710/+122) was cloned to pGL3 basic vector (Promega Corp., Madison, WI) using PCR with a pair of primers: (forward: 5'-ctagctagctagAAAGGAGAGCCACAAGACCA-3'; reverse: 5'-ccgctcgagcggGGAAGGACTGCAAACTCCAC-3'), which contained NheI and XhoI restriction sites (underlined), respectively. Alternatively, two 25-base oligonucleotides: (forward: 5'-ctagCCGCCCCTTACGTGCCCGGCCCCGC-3', reverse: 5'-tcgaGCGGGGCCGGGCACGTAAGGGGCGG-3') corresponding to human cad HRE matrix (-76/-52) were synthesized and cloned into SV40-driven pGL3 plasmid after annealing. Mutation of the putative HRE sequence was achieved by replacing the bases ACGTG with ATTAG.
###end p 17
###begin p 18
###xml 92 95 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
Cells were placed on 24-well plates for luciferase assays. Commercial plasmids containing a CMV-driven beta-galactosidase reporter system (Promega, Madison, WI) were transfected into the cells using Lipofectamine 2000 (Invitrogen Life Technologies, Carlsbad, CA). After transfection, the cells were allowed to rise and incubated in serum-free DMEM/F12 medium for 6 h. The medium was then changed, and cells were subjected to hypoxic treatment for the indicated time. Luciferase assays were done using a kit (Dual Luciferase Reporter Assay System, Promega) according to the manufacturer's instructions. Briefly, 100 microl of luciferase substrates were added to 20 microl of lysate, and luciferase activity was measured using a 20/20 luminometer (Turner Designs, Sunnyvale, CA). Each luciferase assay experiment was performed in duplicate and repeated as indicated in the figure legends.
###end p 18
###begin title 19
SiRNA
###end title 19
###begin p 20
###xml 39 44 <span type="species:ncbi:9606">human</span>
Short interference RNA (siRNA) against human HIF-1alpha was synthesized by Qiagen. Sequences for siHIF-1alpha are: 5'-r(CUGAUGACCAGCAACUUGA)d(TT)-3' and 5'-r(UCAAGUUGCUGGUCAUCAUCAG)d(TT)-3'. For negative control, two ribonucleotides with scrambled sequences 5'-r(AGUUCAACGACCAGUAGUC)d(TT)-3' and 5'-r(GACUACUGGUCGUUGAACU)d(TT)-3' were also synthesized. The ribonucleotides were dissolved in the siRNA suspension buffer (Qiagen), heated to 90degreesC for 1 min, and incubated at 37degreesC for 60 min. The annealed siRNA (5 microg) was used to transfect cells according to manufacturer's instruction (Qiagen). After transfection, cells were incubated with or without 10 mM DFO for 8 h and subjected to RNA isolation and real-time RT-PCR quantification as described above.
###end p 20
###begin title 21
Chromatin immunoprecipitation (ChIP)-PCR assay
###end title 21
###begin p 22
###xml 43 45 43 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b24">24</xref>
###xml 157 158 153 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 650 651 636 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 1654 1655 1606 1607 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 2313 2314 2259 2260 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1285 1291 <span type="species:ncbi:9986">rabbit</span>
The protocol used was as described before (24) with modifications. In brief, proteins (HIF-1alpha) and DNA in normoxia, hypoxia, or DFO-treated cells (1 x 106 cells) were cross-linked by incubation for 10 min at 37degreesC with a final concentration of 1% formaldehyde. After aspiration of the formaldehyde, the cells were washed twice with ice-cold phosphate-buffered saline (PBS) containing protease inhibitors (1 mM phenylmethylsulfonyl fluoride and 1 microg/ml each of aprotinin, and pepstatin A) and scraped into a conical tube. The lysate was then centrifuged in a desktop centrifuge (Model 5415R, Eppendorf, Hamburg, Germany) for 5 min at 500 g at 4degreesC, resuspended in 400 microl of lysis buffer [1% SDS, 10 mM EDTA, and 50 mM Tris-HCl (pH 8.1)], and placed on ice for 10 min. Genomic DNA was sheared to lengths of 0.5-1 kb by sonicating the cell lysate, then debris was removed by centrifugation, and the supernatant diluted with 1 ml of ChIP dilution buffer [0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA, 16.7 mM Tris-HCl, 16.7 mM NaCl and proteinase inhibitors (pH 8.0)]. Two percent of the diluted lysate was kept for input control. The chromatin solution was pre-cleared with mixtures containing BSA, salmon sperm DNA and protein A Sepharose. Anti-HIF-1alpha antibody or rabbit IgG (for negative control) was added to the supernatant fraction and the mixture was incubated overnight at 4degreesC with rotation. Then, 60 microl of salmon sperm DNA/Protein A agarose slurry was added to the mixture and incubated for 1 h at 4degreesC with rotation. The protein A agarose/antibody/HIF-1alpha complex was pelleted by gentle centrifugation (400 g at 4degreesC for 1 min) in a desktop centrifuge (Eppendorf, Model 5415R). The pellet was washed sequentially (5 min per wash) on a rotating platform with 1 ml each of low salt washing buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl and 150 mM NaCl (pH 8.0)], high salt washing buffer [0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris-HCl and 500 mM NaCl (pH 8.0)], LiCl washing buffer [0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate, 1 mM EDTA and 10 mM Tris-HCl (pH 8.0)] and 1x TE buffer [10 mM Tris-HCl and 1 mM EDTA (pH 8.0)]. After the final wash, the pellet was eluted by resuspension in freshly made elution buffer (1% SDS and 50 mM NaHCO3), followed by centrifugation. Twenty microliters of 5 M NaCl was added to the supernatant and the mixture incubated for 4 h at 65degreesC to reverse the protein-DNA crosslinking, and then the DNA was amplified using PCR. The cycling conditions were 95degreesC for 10 min, followed by 30 cycles of 95degreesC for 30 s, 60degreesC for 30 s and 72degreesC for 30 s.
###end p 22
###begin title 23
Statistical analysis
###end title 23
###begin p 24
###xml 313 314 311 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</italic>
###xml 331 332 329 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 443 444 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
The data were expressed as mean +/- standard error of the mean (SEM). Differences between groups were analyzed using one-way ANOVA in commercial statistical software (GraphPad Prism 4.02; GraphPad Software, San Diego, CA). Tukey's procedure was used to test differences between groups found significant using the F-test. Student's t-test was used to compare differences between normoxic and hypoxic groups. Statistical significance was set at P < 0.05.
###end p 24
###begin title 25
RESULTS
###end title 25
###begin title 26
Expression of CAD is cell-cycle-dependent
###end title 26
###begin p 27
###xml 581 589 579 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 808 816 806 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 974 982 972 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
###xml 1123 1131 1121 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Figure 1</xref>
The expression of CAD provides a functional enzyme for the biosynthesis of pyrimidine nucleotides, the critical constituent for DNA synthesis and cell-cycle progression. To determine the expression levels of CAD in different cell types, mRNA encoding for CAD was quantified using real-time RT-PCR. The expression level of CAD was associated with the proliferation speed of each cancer cell line. Expression levels for the colo320DM and IMR32 lines (doubling time: </= 24 h) were significantly higher than for the primary cultured endometrial stromal cells (doubling time: > 48 h) (Figure 1). In addition, expression of CAD was cell-cycle-dependent. In colo320DM cells, CAD transcripts increased 4 h after serum stimulation, reached peak value at 8 h, returned to basal level at 16 h, and rose again at 24 h (Figure 1). Levels of CAD mRNA in IMR32 did not increase until 8 h after serum stimulation, maintained at the high value at 16 h, and returned to basal level at 24 h (Figure 1). In stromal cells, which showed no measurable proliferation within 24 h after serum stimulation, the CAD level predictably did not change (Figure 1).
###end p 27
###begin title 28
Hypoxia inhibits the expression of CAD mRNA
###end title 28
###begin p 29
###xml 153 154 153 154 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 292 301 292 301 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2A</xref>
###xml 643 652 643 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2B</xref>
###xml 764 767 764 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 775 776 775 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b2">2</xref>
###xml 1368 1377 1368 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Figure 2C</xref>
###xml 442 447 <span type="species:ncbi:9606">human</span>
In order to investigate whether the expression of CAD is regulated by hypoxia, we compared the mRNA levels of CAD in cells cultured under normoxic (21% O2) or hypoxic (1% O2) conditions. In colo320DM cells exposed to hypoxia, CAD mRNA expression was significantly reduced at all time points (Figure 2A). To test whether hypoxia-induced suppression of CAD mRNA expression is a common effect, three other cell lines (A293T, IMR32 and HeLa) and human endometrial stromal cells were exposed to normoxia or hypoxia for 16 h, and their levels of mRNA were analyzed. Hypoxia treatment significantly inhibited CAD mRNA expression in all cells tested (Figure 2B), which indicated that it is a common phenomenon. It has been reported that hypoxia may induce apoptosis in p53+/+ cells (2). To test whether the decrease in CAD mRNA expression under hypoxia condition is due to hypoxia-induced cell death, cell numbers were calculated 16 h after hypoxia treatment. No significant decreases in cell numbers were observed in any of the cell lines used (data not shown). In addition, expression of another hypoxia-regulated gene, VEGF, was examined using simple RT-PCR as an internal control because hypoxia induces VEGF expression in many cell types and solid tumors. In fact, VEGF expression increased in cells exposed to hypoxia for 24 h even though CAD mRNA expression decreased (Figure 2C). Together, these data demonstrate that hypoxia specifically suppressed CAD mRNA expression.
###end p 29
###begin title 30
Suppression of CAD expression under chemical hypoxia
###end title 30
###begin p 31
###xml 323 332 315 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 535 544 523 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3A</xref>
###xml 682 691 670 679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 930 939 918 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3B</xref>
###xml 1048 1057 1036 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figure 3C</xref>
Hypoxia-regulated gene expression is either HIF-1-dependent or HIF-1-independent. To determine whether suppression of CAD expression under hypoxia is mediated by HIF-1, cells were treated with DFO, an iron chelator that causes HIF-1alpha to accumulate. DFO treatment caused a dose-dependent increase in nuclear HIF-1alpha (Figure 3A). A time-course experiment demonstrated that accumulation of HIF-1alpha had discernibly accumulated in the nucleus 4 h after treatment in colo320DM cells, peaked at 8 h, and remained for at least 24 h (Figure 3A, D4, D8, D16, D24). Similarly, the expression of CAD was time-dependently suppressed after treatment with DFO under normoxic conditions (Figure 3B). Although the suppression pattern was somewhat different in different cell types, it seems clear that DFO reduced CAD expression in all four cell lines (colo320DM, HeLa, A293T and IMR32) as well as in the primary cultured stromal cells (Figure 3B). Again, the cell number did not decrease (data not shown) and DFO upregulated the expression of VEGF mRNA (Figure 3C and data not shown), which indicated DFO did not induce apoptosis in these cells within 24 h.
###end p 31
###begin title 32
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 36 41 <span type="species:ncbi:9606">human</span>
Identification of functional HRE in human cad-gene promoter
###end title 32
###begin p 33
###xml 148 151 148 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 401 410 401 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4A</xref>
###xml 494 497 494 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 629 632 629 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 703 712 703 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4B</xref>
###xml 803 812 799 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4C</xref>
###xml 908 917 904 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4D</xref>
###xml 1068 1071 1064 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1219 1222 1215 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1233 1242 1229 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Figure 4E</xref>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 488 493 <span type="species:ncbi:9606">human</span>
Based on these data, we investigated whether repression of CAD by hypoxia could be regulated by HIF-1 at the transcriptional level. The sequence of cad promoter, available in the human genome database (Ensembl), was retrieved and analyzed for putative HRE sites using a hidden Markov model (HMM). An HRE matrix-containing the core sequence (5'-RCGTG-3') was identified at the -67/-54 of cad promoter (Figure 4A). To test whether this HRE matrix is functional, the 5'-flanking sequence of human cad (-710/+122) was cloned to a pGL3 basic luciferase reporter plasmid. Exposing cells transiently transfected with plasmid containing cad promoter to 1% oxygen significantly reduced reporter-gene expression (Figure 4B); the reduction was inversely correlated with the elevation of HIF-1alpha in the nucleus (Figure 4C). This result was indisputably replicated in primary culture cells and three other cell lines (Figure 4D and data not shown) indicating, again, that it is a common event. Because DFO treatment also reduced CAD expression, we tested whether DFO suppressed cad-promoter activity. As expected, treatment with DFO dose-dependently reduced reporter-gene expression in cells transfected with plasmids containing cad promoter (Figure 4E).
###end p 33
###begin p 34
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 280 283 280 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 378 387 378 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5A</xref>
###xml 536 545 536 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 663 672 663 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 274 279 <span type="species:ncbi:9606">human</span>
###xml 339 343 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 428 432 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
One study reported that the core HRE (5'-RCGTG-3') is necessary but not sufficient for HIF-mediated promoter activity (25). To test whether this HRE matrix is indeed a functional HIF-1-regulated region, two 25 bp oligonucleotides corresponding to the -76/-52 segment of the human cad-gene promoter region were synthesized and cloned to an SV40 promoter containing pGL3 plasmid (Figure 5A). Insertion of the HRE matrix into pGL3-SV40 plasmid caused a 2-fold increase in promoter activity when cells were cultured in normoxic conditions (Figure 5B). When exposed to hypoxia, reporter-gene expression decreased in cells transfected with this HRE-containing plasmid (Figure 5B).
###end p 34
###begin p 35
###xml 33 36 33 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b26">26</xref>
###xml 346 355 346 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5B</xref>
###xml 433 436 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 511 520 511 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 657 666 657 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5C</xref>
###xml 735 738 731 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 817 826 813 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5D</xref>
###xml 921 924 913 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 971 980 963 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5E</xref>
###xml 1170 1179 1158 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figure 5F</xref>
###xml 1315 1318 1299 1302 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 73 77 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 154 158 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1063 1067 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
To examine whether the effect of cad HRE was due to alteration of intact SV40 promoter, a 47 bp VEGF HRE (26) was cloned to the same position in the pGL3-SV40 plasmid, and luciferase activity was measured. The VEGF HRE did not alter promoter activity under normoxic conditions but it did induce reporter-gene expression under hypoxic conditions (Figure 5B). Similarly, cells transfected with plasmid containing the HRE matrix of the cad gene showed reduced promoter activity after being treated with 10 mM DFO (Figure 5C). In contrast, DFO treatment did not inhibit reporter-gene expression in cells transfected with plasmids containing mutated HRE matrix (Figure 5C). Forced expression of wild-type HIF-1alpha significantly inhibited cad-promoter activity and this effect was further substantiated by DFO treatment (Figure 5D). Inversely, transfection with dominant-negative HIF-1alpha plasmid dose-dependently restored cad-promoter activity inhibited by DFO treatment (Figure 5E). DFO treatment induced reporter-gene activity in cells co-transfected with pVEGF-SV40 and control plasmid, but this effect was abolished by overexpression of dominant-negative HIF-1alpha (Figure 5F). Taken together, these data provide further evidence that supports the functional role of HIF-1alpha in transcriptional repression of cad-gene activity in a gene-specific manner.
###end p 35
###begin title 36
###xml 15 18 15 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
Suppression of cad-gene expression under hypoxia is HIF-1alpha dependent
###end title 36
###begin p 37
###xml 83 86 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 445 454 425 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6A</xref>
###xml 567 576 547 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
###xml 671 680 647 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Figure 6B</xref>
To determine the crucial role of HIF-1alpha in hypoxia-mediated down-regulation of cad-gene expression, specific siRNA against HIF-1alpha was used to knock down HIF-1alpha and expression of CAD transcripts were determined under chemical hypoxia. Transfection of HIF-1alpha siRNA (siHIF) significantly inhibited DFO-induced HIF-1alpha protein accumulation while transfection of siRNA with scrambled sequence (sr-HIF) did not have similar effect (Figure 6A). Levels of endogenous CAD transcripts were significantly decreased in mock transfected cells treated with DFO (Figure 6B). The suppressive effect was reversed by prior transfection with siHIF-1alpha but not sr-HIF (Figure 6B) indicating suppression of CAD expression by DFO is HIF-1alpha dependent.
###end p 37
###begin title 38
###xml 29 32 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
Binding of HIF-1alpha to the cad-promoter HRE
###end title 38
###begin p 39
###xml 70 73 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 146 149 138 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 184 187 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 319 322 307 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 403 406 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 449 458 433 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A</xref>
###xml 625 634 609 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7A</xref>
###xml 706 715 690 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 747 750 727 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 860 869 840 849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 933 936 909 912 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1020 1029 996 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figure 7B</xref>
###xml 565 571 <span type="species:ncbi:9986">rabbit</span>
So far, we have identified that HIF-1alpha transcriptionally inhibits cad-gene expression. To demonstrate that HIF-1alpha physically binds to the cad-promoter HRE matrix and regulates cad-gene activity, colo320DM cells were exposed to normoxia or hypoxia for different periods of time, and the binding of HIF-1alpha to cad promoter was analyzed using a ChIP assay. HIF-1alpha bound significantly to the cad promoter by 16 h after hypoxia treatment (Figure 7A). In contrast, non-specific binding was unaffected by hypoxia treatment, as demonstrated by results using rabbit IgG as the primary antibody for immunoprecipitation (Figure 7A). Similar results were obtained when cells were treated with 1 mM DFO (Figure 7B). The binding of HIF-1alpha to cad promoter was significantly increased by DFO treatment by as early as 4 h, and it remained so for up to 24 h (Figure 7B). In IMR32 neuroblastoma cells, basal binding of HIF-1alpha to cad promoter under normoxia was greater, but DFO treatment also increased the binding (Figure 7B).
###end p 39
###begin title 40
DISCUSSION
###end title 40
###begin p 41
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
###xml 177 178 177 178 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b7">7</xref>
###xml 367 370 363 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 481 483 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 484 486 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 684 687 676 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 925 928 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1085 1088 1061 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1147 1150 1123 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 678 683 <span type="species:ncbi:9606">human</span>
Hypoxic stress inhibits de novo biosynthesis of pyrimidine nucleotides, thus leading to cell-cycle arrest due to an insufficient supply of building materials for DNA synthesis (7). Nevertheless, how hypoxia causes reduction in pyrimidine biosynthesis remains enigmatic. The present study provides evidence demonstrating that HIF-1alpha transcriptionally inhibits the cad gene, which encodes a multifunctional enzyme that controls the rate-limiting step of pyrimidine biosynthesis (15,16). This conclusion is based on results obtained in experiments in which CAD expression declined in response to an increase in cellular levels of HIF-1alpha. A functional HRE was identified in human cad promoter, which was bound by HIF-1alpha as demonstrated by the ChIP assay. The use of dominant-negative form HIF-1alpha totally abolished the hypoxic effect provided further evidence to show the pivotal role of HIF-1alpha in suppressing cad-promoter activity. Furthermore, increasing HIF-1alpha levels in colo320DM, HeLa, A293T, IMR32 and primary endometrial stromal cells significantly inhibited cad expression, which unequivocally proved that repression of cad-promoter activity by HIF-1alpha is common in hypoxic cells. Taken together, our current data provide evidence to support that hypoxia-induced cell-cycle arrest might be the result of the inhibition of CAD expression by HIF-1alpha.
###end p 41
###begin p 42
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b27">27</xref>
###xml 469 471 469 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b28">28</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b29">29</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b15">15</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b16">16</xref>
###xml 1680 1681 1676 1677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b1">1</xref>
###xml 1379 1384 <span type="species:ncbi:9606">human</span>
DNA synthesis diminishes when oxygen is reduced from cell culture (27), which ultimately leads to cell-cycle arrest at the G1/S-phase. Previous studies focused on two oxygen-dependent enzymes, ribonucleotide reductase and dihydroorotate dehydrogenase. They concluded by hypothesizing that inactivation of these enzymes under hypoxia is the primary cause of a shortage of deoxynucleotide precursors for DNA replication and a consequent arrest of cell-cycle progression (28,29). However, these two enzymes work downstream of CAD, and other studies (15,16) suggest that the rate-limiting reaction of the entire pyrimidine synthesis is actually controlled at the step of converting glutamine to dihydroorotate, which involves three enzymatic activities possessed by CAD. In agreement with these reports, our results demonstrated that the expression of CAD is highly associated with the cell-cycle progression and the expression level of CAD truly reflects the proliferation rate of cells. The highest level of CAD expression in colo320DM cells occurred between 4 and 8 h after serum stimulation, which demonstrates CAD's functional role of providing nucleotides for DNA replication. Furthermore, we found that oxygen deprivation or increased cellular HIF-1alpha levels induced by DFO treatment significantly reduced the levels of CAD transcripts in colo320DM, HeLa, A293T, IMR32 and human endometrial stromal cells. These results not only demonstrate hypoxia-down-regulated CAD expression is a common phenomenon but also provide evidence to support the notion that hypoxia-induced cell-cycle arrest is directly related to the shortage of deoxynucleotide precursors for DNA synthesis (1).
###end p 42
###begin p 43
###xml 326 328 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b30">30</xref>
###xml 329 331 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b31">31</xref>
###xml 640 642 633 635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b25">25</xref>
###xml 643 645 636 638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b32">32</xref>
###xml 646 648 639 641 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b33">33</xref>
###xml 753 756 746 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 848 851 837 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 959 962 948 951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1129 1132 1114 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1217 1220 1202 1205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1259 1262 1244 1247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1433 1436 1410 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1496 1499 1473 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 747 752 <span type="species:ncbi:9606">human</span>
###xml 953 958 <span type="species:ncbi:9606">human</span>
###xml 1123 1128 <span type="species:ncbi:9606">human</span>
The expression of hypoxia-responsive genes is primarily regulated by HIF-1alpha/HIF-1beta transcription factor. The HIF heterodimer binds to a specific DNA-binding element, the HRE matrix, which contains a core sequence (5'-RCGTG-3')and uncharacterized flanking sequences in the promoter region or other untranslated regions (30,31). Owing to the shortness of the sequence, the core HREs were observed frequently in the target-gene promoter, but only a few of them are effective for hypoxia-regulated gene expression. Cumulative data have demonstrated that the core HRE is necessary but not sufficient to regulate hypoxia-responsive genes (25,32,33). By using bioinformatic methodology, we identified one such HRE matrix in the proximal region of human cad promoter (-67/-54) and confirmed that this HRE matrix is important in HIF-1alpha-regulated cad-promoter activity by providing several lines of evidence. First, the promoter activity of the intact human cad promoter (-710/+122) was down-regulated under hypoxic condition or an increase in nuclear HIF-1alpha concentrations caused by DFO treatment. Second, the 25 bps human cad HRE matrix-containing plasmid responded to hypoxic stress exactly as that of intact cad promoter. Third, effect of hypoxia on cad-promoter activity was abrogated when the 25 bp HRE was mutated or by forced overexpression of dominant-negative HIF-1alpha. Fourth, physical binding of HIF-1alpha to the cad promoter was demonstrated by ChIP assay and the amounts of cad promoter-bound HIF-1alpha was significantly increased under hypoxic conditions.
###end p 43
###begin p 44
###xml 18 21 18 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 219 220 211 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b4">4</xref>
###xml 297 300 289 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 360 363 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 435 437 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b34">34</xref>
###xml 587 589 571 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b35">35</xref>
###xml 826 829 802 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1062 1065 1038 1041 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1072 1074 1048 1050 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="b36">36</xref>
###xml 1205 1208 1177 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1332 1335 1304 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
The repression of cad-promoter activity by HIF-1alpha concurs with the notion that hypoxia causes a halt of pyrimidine nucleotide biosynthesis and that HIF-1alpha is indispensable for hypoxia-induced cell-cycle arrest (4). However, the in-depth mechanism responsible for inhibiting HIF-1-mediated cad-gene expression is not completely elucidated. The proximal cad promoter contains an E-box essential for c-Myc-induced CAD expression (34). It has been reported that HIF-1alpha can counteract c-Myc's function independent of HIF-1alpha's transcriptional activity and DNA-binding ability (35). In the current study, by showing that dominant-negative HIF-1alpha blocked the effects of hypoxia, we found that the binding of HIF-1alpha to the HRE matrix and retention of transcriptional capability are necessary for suppression of cad-promoter activity. Alternatively, it was reported that ATP-dependent hSWI/SNF chromatin remodeling complex containing mSin3A/histone deacetylase 2 (HDAC2) co-repressor might also be involved in the transcriptional repression of the cad gene (36). It is possible that the binding of HIF-1alpha to the HRE matrix recruits histone modification complex or other co-repressors to cad promoter and thus suppresses gene transcription. Further investigations on the nature of the partners of HIF-1 involved in cad down-regulation are crucial to elucidate the mechanisms involved in the repression of HIF-1-dependent hypoxia down-regulated genes.
###end p 44
###begin p 45
###xml 97 100 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
In summary, we have demonstrated for the first time that HIF-1alpha transcriptionally suppressed cad-gene expression under hypoxia. This effect was unequivocally observed in four cancerous and non-cancerous cell lines and one primary culture cell type, which demonstrated that it is a common phenomenon. Given the critical role of CAD in nucleotides biosynthesis and consequent DNA replication, our data provide a functional link between hypoxia and cell-cycle arrest. Further investigation is warranted to explore effects of CAD suppression on the upregulation of checkpoint proteins and cell-cycle arrest when cells are under hypoxic stress, which may provide valuable information in designing novel regimens for treating hypoxia-related diseases.
###end p 45
###begin p 46
This work was supported by grants NSC94-3112-B006-010 and NSC92-3112-B006-019-Y from the National Science Council of Taiwan. Funding to pay the Open Access publication charges for this article was provided by the National Science Council of Taiwan.
###end p 46
###begin p 47
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 47
###begin title 48
REFERENCES
###end title 48
###begin article-title 49
The retinoblastoma protein-associated cell cycle arrest in S-phase under moderate hypoxia is disrupted in cells expressing HPV18 E7 oncoprotein
###end article-title 49
###begin article-title 50
Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
###end article-title 50
###begin article-title 51
Regulation of proliferation-survival decisions during tumor cell hypoxia
###end article-title 51
###begin article-title 52
Hypoxia-inducible factor 1alpha is essential for cell cycle arrest during hypoxia
###end article-title 52
###begin article-title 53
Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
###end article-title 53
###begin article-title 54
Hypoxia inhibits G1/S transition through regulation of p27 expression
###end article-title 54
###begin article-title 55
The biosynthetic pathway of pyrimidine (deoxy)nucleotides: a sensor of oxygen tension necessary for maintaining cell proliferation?
###end article-title 55
###begin article-title 56
p21(Cip1) and p27(Kip1) regulate cell cycle reentry after hypoxic stress but are not necessary for hypoxia-induced arrest
###end article-title 56
###begin article-title 57
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
###end article-title 57
###begin article-title 58
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
In vivo expression of mRNAs encoding hypoxia-inducible factor 1
###end article-title 58
###begin article-title 59
Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells
###end article-title 59
###begin article-title 60
A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development
###end article-title 60
###begin article-title 61
Molecular mechanisms of vasculogenesis and embryonic angiogenesis
###end article-title 61
###begin article-title 62
Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status
###end article-title 62
###begin article-title 63
###xml 78 85 78 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de novo</italic>
Purification from hamster cells of the multifunctional protein that initiates de novo synthesis of pyrimidine nucleotides
###end article-title 63
###begin article-title 64
###xml 146 153 146 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">de Novo</italic>
###xml 23 28 <span type="species:ncbi:9606">human</span>
Molecular cloning of a human cDNA encoding a trifunctional enzyme of carbamoyl-phosphate synthetase-aspartate transcarbamoylase-dihydroorotase in de Novo pyrimidine synthesis
###end article-title 64
###begin article-title 65
Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis
###end article-title 65
###begin article-title 66
Regulation of carbamoyl phosphate synthetase by MAP kinase
###end article-title 66
###begin article-title 67
Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells
###end article-title 67
###begin article-title 68
Towards a further understanding of the growth-inhibiting action of oxygen deficiency. Evaluation of the effect of antimycin on proliferating Ehrlich ascites tumour cells
###end article-title 68
###begin article-title 69
Characterization of the deoxynucleoside-dependent reversal of hypoxia-induced inhibition of cell cycle progression in Ehrlich ascites tumor cells
###end article-title 69
###begin article-title 70
Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells
###end article-title 70
###begin article-title 71
Fibroblast growth factor-9 is an endometrial stromal growth factor
###end article-title 71
###begin article-title 72
###xml 61 66 <span type="species:ncbi:9606">human</span>
Transactivation of steroidogenic acute regulatory protein in human endometriotic stromal cells is mediated by the prostaglandin EP2 receptor
###end article-title 72
###begin article-title 73
###xml 94 95 94 95 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension
###end article-title 73
###begin article-title 74
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
###end article-title 74
###begin article-title 75
###xml 27 32 <span type="species:ncbi:9606">human</span>
Oxygen modulates growth of human cells at physiologic partial pressures
###end article-title 75
###begin article-title 76
Ribonucleotide reductase, a possible agent in deoxyribonucleotide pool asymmetries induced by hypoxia
###end article-title 76
###begin article-title 77
Regulation of cell proliferation under extreme and moderate hypoxia: the role of pyrimidine (deoxy)nucleotides
###end article-title 77
###begin article-title 78
Possible function of Ah receptor nuclear translocator (Arnt) homodimer in transcriptional regulation
###end article-title 78
###begin article-title 79
Contribution of the PAS domains to DNA binding by the basichelix-loop-helix PAS transcriptional regulators
###end article-title 79
###begin article-title 80
DNA binding specificities and pairing rules of the Ah receptor, ARNT, and SIM proteins
###end article-title 80
###begin article-title 81
The role of the aryl hydrocarbon receptor nuclear translocator (ARNT) in hypoxic induction of gene expression. Studies in ARNT-deficient cells
###end article-title 81
###begin article-title 82
c-Myc target gene specificity is determined by a post-DNAbinding mechanism
###end article-title 82
###begin article-title 83
HIF-1alpha induces cell cycle arrest by functionally counteracting Myc
###end article-title 83
###begin article-title 84
mSin3A/histone deacetylase 2- and PRMT5-containing Brg1 complex is involved in transcriptional repression of the myc target gene cad
###end article-title 84
###begin title 85
Figures and Tables
###end title 85
###begin p 86
###xml 405 406 405 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 508 513 <span type="species:ncbi:9606">human</span>
Expression of CAD mRNA in different cell types after serum stimulation. Cells were serum-starved for 24 h and then incubated in fresh medium containing 10% serum. Total RNA was isolated from cells at time points indicated and subjected to RT-PCR amplification. Concentrations of CAD transcripts were determined by real-time RT-PCR. Different letters indicate significant difference within each cell type (P < 0.05). Colo320DM: colon cancer cell line, IMR32: neuroblastoma cell line, stroma: primary cultured human uterine endometrial stromal cells.
###end p 86
###begin p 87
###xml 41 42 41 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 210 211 210 211 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 250 251 250 251 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 572 573 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 637 638 637 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 646 647 646 647 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 1044 1045 1044 1045 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 920 925 <span type="species:ncbi:9606">human</span>
###xml 984 989 <span type="species:ncbi:9606">human</span>
Hypoxia suppresses CAD mRNA expression. (A) Colo320DM cells were serum-starved for 24 h followed by addition of fresh medium supplemented with 10% FBS. Cells were then cultured in hypoxic chamber (hypoxia, 1% O2) or regular incubator (normoxia, 21% O2) for 4, 8, 16 and 24 h, respectively. Total RNA was isolated and levels of CAD transcripts were determined by real-time RT-PCR as described in experimental procedures. The data show means and standard errors obtained from three independent experiments performed in duplicated. Asterisk indicates significant difference (P < 0.05) compared to same time point normoxia group by unpaired t-test. (B) Serum-starved cells were cultured in fresh medium supplemented with 10% FBS under normoxia and hypoxia conditions, respectively for 16 h and expression of CAD mRNA was quantified. Data show mean values of hypoxia to normoxia ratio of three independent experiments. Three human cell lines (293T, HeLa and IMR32) and one primary culture human uterine endometrial stromal cell (stroma) were used. (C) Serum-starved Colo320DM cells were cultured in fresh medium supplemented with 10% FBS under normoxia and hypoxia conditions, respectively for 16 h and expression of CAD and VEGF mRNA was determined by simple RT-PCR.
###end p 87
###begin p 88
###xml 69 70 69 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 471 472 460 461 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 762 763 751 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 817 818 806 807 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
Hypoxia-suppressed CAD expression can be mimicked by DFO treatment. (A) Serum-starved colo320DM cells were cultured in fresh medium containing 10% FBS in the presence or absence of different concentrations of DFO and levels of nuclear HIF-1alpha and HIF-1beta were determined (upper panel). Lower panel shows that nuclear HIF-1alpha in cells treated with 10 mM DFO for different length of time as indicated. This experiment was repeated three times with similar result. (B) Serum-starved cells were cultured in fresh medium supplemented with 10% FBS in the presence or absence of 10 mM DFO for 0, 4, 8, 16 or 24 h. Expression of CAD transcripts were quantified by real-time RT-PCR. Data represent mean value of ratio to untreated control at the same time point (n = 3-4 for each cell types quantified in duplicate). (C) A representative gel picture shows RT-PCR products of CAD and VEGF after DFO treatment for 24 h.
###end p 88
###begin p 89
###xml 60 61 56 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 90 93 86 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 284 285 280 281 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 373 376 369 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 439 440 435 436 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 468 469 464 465 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 676 677 672 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 687 688 683 684 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 803 804 795 796 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 811 812 803 804 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 821 822 813 814 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 896 897 888 889 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 988 991 980 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 1223 1224 1215 1216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1234 1235 1226 1227 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1506 1507 1498 1499 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 43 48 <span type="species:ncbi:9606">human</span>
###xml 84 89 <span type="species:ncbi:9606">human</span>
###xml 367 372 <span type="species:ncbi:9606">human</span>
###xml 915 920 <span type="species:ncbi:9606">human</span>
###xml 982 987 <span type="species:ncbi:9606">human</span>
HIF-1alpha suppressed promoter activity of human cad gene. (A) Schematic drawing of human cad-gene promoter shows location and sequences of bioinformatic predicted HRE matrix with core HRE in underlined bold face. Arrows indicate primers for chromatin immunoprecipitation-PCR assay. (B) Colo320DM cells was transfected with pGLbasic plasmid or pGL basic plasmid with human cad promoter (designated as pCAD) and subjected to normoxia (21% O2) or hypoxia treatment (1% O2) as described in experimental procedures. Data show means and standard errors of three independent experiments performed in duplicate. Asterisk indicates significant difference compared to normoxia group a P < 0.05. (C) A representative western blot result shows nuclear HIF-1alpha and laminin in cells cultured under normoxia (21% O2), 8% O2, or 1% O2 for 16 h. This experiment was repeated three times with similar result. (D) Primary culture human endometrial stromal cells were treated as described in B and human cad-promoter activity was determined. Data show means and standard errors of four independent experiments using different batches of cells performed in duplicate. Asterisk indicates significant difference compared to normoxia group at P < 0.05. (E) Transfected colo320DM cells were treated with different concentrations of DFO for 16 h and promoter activity was determined. Data show means and standard errors of three independent experiments performed in duplicate. Different letters indicate significant difference (P < 0.05).
###end p 89
###begin p 90
###xml 65 68 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 89 90 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 178 181 174 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 249 250 245 246 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 786 787 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 796 797 792 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 807 808 803 804 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 1189 1190 1185 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 1199 1200 1195 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1210 1211 1206 1207 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 1481 1482 1473 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1544 1545 1536 1537 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 1562 1563 1554 1555 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 1909 1910 1897 1898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 172 177 <span type="species:ncbi:9606">human</span>
###xml 235 239 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 294 298 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 336 340 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 509 513 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 535 539 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 874 878 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 899 903 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1538 1542 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1556 1560 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Effect of dominant-negative form HIF-1alpha on hypoxia-regulated cad-promoter activity. (A) Schematic drawing of reporter constructs depicts that the 25-base HRE matrix of human cad gene was inserted between NheI and XhoI sites of pGL-SV40 vector. (B) Colo320DM cells were transfected with pGL-SV40 vector or HRE matrix-containing pCAD-SV40 plasmid and subjected to normoxia or hypoxia treatment as described in experimental procedure. As positive control, a 47-base VEGF HRE was also ligated to the same pGL-SV40 vector (termed pVEGF-SV40) and was used to perform identical experiment as described above side-by-side. Data show means and standard errors of three independent experiments performed in duplicate. Asterisk indicates significant difference from normoxia group by unpaired t-test at P < 0.05. (C) Cells were transfected with plasmids containing wild-type (pCAD-SV40) or mutated (pMuCAD-SV40) HRE as described. Transfected cells were then treated with 10 mM DFO for 16 h and luciferase activity was measured. Data show means and standard errors of three independent experiments performed in duplicate. Asterisk indicates significant difference from untreated group by unpaired t-test at P < 0.05. (D) Cells were co-transfected with pCAD and HIF-1alpha or control vector and then treated with or without DFO (10 mM) for 16 h. Data show means and standard errors of three independent experiments performed in duplicate. Different letters indicate significant difference (P < 0.05). (E and F) Cells were co-transfected with pCAD-SV40 (E) or pVEGF-SV40 (F) and different amounts of dominant-negative HIF-1alpha vector (DN-HIF) or control vector as indicated. Transfected cells were then treated with 10 mM DFO for 16 h and luciferase activity was measured. Data show means and standard errors of three independent experiments performed in duplicate. Different letters indicate significant difference (P < 0.05).
###end p 90
###begin p 91
###xml 432 433 420 421 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 628 629 608 609 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 794 795 774 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
DFO-mediated suppression of CAD mRNA is HIF-1alpha dependent. Cells were transfected with specific siRNA against HIF-1alpha (siHIF), scrambled sequence of siRNA (sr-HIF), or transfection reagent only (Mock) as indicated. Transfected cells were then treated with 10 mM DFO or vehicle (Con) for 8 h and levels of endogenous HIF-1alpha protein (A) and CAD mRNA transcripts (B) were determined by western blot and/or real-time RT-PCR. (A) a representative western blot shows that HIF-1alpha was induced by DFO treatment in cells transfected with scrambled siRNA or mock transfection but not in cells transfected with siHIF-1alpha. (B) Data show means and standard errors of three independent experiments performed in duplicate. Asterisks indicate significant difference from vehicle treated group (P < 0.05).
###end p 91
###begin p 92
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vivo</italic>
###xml 74 77 70 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cad</italic>
###xml 89 90 85 86 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 443 444 427 428 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 319 325 <span type="species:ncbi:9986">rabbit</span>
In vivo binding of HIF-1alpha on the HRE matrix located at -67/-54 of the cad promoter. (A) Colo320DM cells were cultured under normoxia (N) or hypoxia (H) conditions for 16 h as described and subjected to chromatin immunoprecipitation-PCR amplification (ChIP) assay.Anti-HIF-1alpha polyclonal antibody (HIF-1alpha) or rabbit IgG (IgG) was used to precipitated sonicated chromatin. Sonicated cell lysate (2 microl) was used as input control. (B) Colo320DM and IMR32 cells were treated with DFO (10 mM for Colo320DM and 1 mM for IMR32, respectively) for indicated time and ChIP assays were performed. V: DMSO vehicle treated groups, D: DFO-treated groups. Number indicates time of treatment in hour. The gel pictures are representative of four independent experiments.
###end p 92

